PTGS2 and ductal breast carcinoma in situ: Our previous work showed that loss of telomere DNA is associated with a telomere-malfunction signature characterized by higher γH2AX (a DNA-damage marker), activin A, and COX-2 expression, in DCIS epithelia [5].